AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.250
+0.050 (2.27%)
Jul 20, 2026, 4:00 PM EDT - Market closed
AC Immune Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, AC Immune stock has a consensus rating of "Strong Buy" and an average price target of $8.51. The average 1-year stock price forecast is 278.22% higher than the current stock price, while the lowest is $5.39 (+139.56%) and the highest is $11.99 (+432.89%).
Price Target: $8.51 (+278.22%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AC Immune stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +433.33% | Jul 1, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 7, 2026 |
| BTIG | BTIG | Buy Maintains $8 | Buy | Maintains | $8 | +255.56% | Mar 16, 2026 |
Financial Forecast
Revenue This Year
36.27M
from 3.57M
Increased by 915.07%
Revenue Next Year
70.26M
from 36.27M
Increased by 93.71%
EPS This Year
-0.48
from -0.70
EPS Next Year
0.26
from -0.48
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CHF.